Partisan Management Group

Contact: Norman R Weldon, Managing Director    Email this Investor

• Biotechnology
• Business and consumer products
• Computer hardware
• Financial services
• Healthcare
• IT services
• Industrial and energy products
• Media and entertainment
• Medical Equipment
• Networking
• Retailing and distribution
• Semiconductors
• Software
• Telecommunications
• Real estate

• Seed
• 1st Round
• 2nd Round
• 3rd Round
• 4th Round and later
• Pre-IPO
• Mezzanine
• Buyout/acquisition

• Private Company (backed by venture capital firms)
• Private Company (not backed by venture capital firms)
• Public Company

Partisan Management Group is a highly successful, early stage venture capital investor in medical device companies. Partisan has sought differentiation from other venture groups in four distinct ways. First, the funds managed by Partisan are provided entirely by the two principals of the firm. Second, Partisan begins by identifying large, unmet medical needs before clinical and investment focus by others. Partisan often creates or licenses intellectual property and initially forms a wholly owned new company. Third, Partisan selects a management team whom the principals can treat as partners for the duration of the investment. A cooperative working relationship is enhanced, enabling management to purchase large amounts of founder's stock. Fourth, Partisan principals use their years of industry experience to integrate a new company's operational needs and its investment needs, often acting as senior officers as well as board members. Partisan typically provides the founding round of capital and then leads a seed round with its network of angel investors or selected venture firms. The principals of Partisan have participated in fifteen medical device startups, of which three (Corvita, Novoste and AtriCure) have become public companies; seven (including one of the public companies) have been sold, and six are private operating companies as of January 2008. Seven of the Partisan companies are cardiovascular device industry participants, two have developed minimally invasive surgical instruments, two treat neurological conditions, one pioneered a new type of dental implant, one developed new drug delivery technology, one is focused on aesthetic medicine, and one develops ethnographically designed self-treatment kits for chronic diseases.

Email this Investor